People · Operator
Named in public records as an officer, director or promoter · active 2013–2014 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Breakthrough Products, Inc. | — | Other Health Care | Series B | $38.8M | $437.0M | 2013 |
Dave Leyrer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dave Leyrer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert King | 1 | 7 |
| Randall Kaplan | 1 | 4 |
| Michael J. Valentino | 1 | 3 |
| Lynne J. Millheiser | 1 | 1 |
| David T. Leyrer | 1 | 1 |
| Candace J. Crawford | 1 | 1 |
| Mike Valentino | 1 | 1 |
| Jordan Eisenberg | 1 | 1 |
| Ron Fugate | 1 | 1 |
| Philip Levin | 1 | 1 |
| Ronald T. Fugate | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.